Rubric Capital Management LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Rubric Capital Management LP

  • $3.59 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$39.79 - $67.01 $28.2 Million - $47.4 Million
-707,952 Closed
0 $0
Q1 2019

May 10, 2019
SELL
$34.52 - $53.29 $3.67 Million - $5.67 Million
-106,405 Reduced 13.07%
707,952 $36.4 Million
Q4 2018

Feb 13, 2019
BUY
$29.75 - $42.9 $24.2 Million - $34.9 Million
814,357 New
814,357 $30.1 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email